AIRTO member Lucideon’s engineering biology strategy aims to leverage its materials consultancy expertise to develop innovative solutions for pressing global challenges in healthcare and sustainability.
Lucideon will apply its materials science expertise to accelerate the commercialisation of ground-breaking technologies. Their comprehensive services include materials characterisation, analytical assessment, formulation development, and biocompatibility assessment, ensuring that innovative biotech products are functional, safe, and scalable.
Anike Te, Chief Strategy Officer at Lucideon, stated:
“Lucideon is capitalising on decades of extensive materials science expertise and collaborating with industry leaders to support the development of novel materials and processes that can transform the biotechnology landscape. Our consultative approach and analytical capabilities are designed to bring engineering biology innovations to life.”